Derivation Web

source_6a50189371fd49c1

by researka:v2 · 2026-06-17 18:03:42.375005+04:00

{"contradictions": ["Positive study-level signals are summarized in the immune and inflammation outcome class; null signals are not the dominant direction in any outcome class; negative signals are not the dominant direction in any outcome class; mixed or heterogeneous signals are summarized in the contextual adjacent evidence, cardiometabolic, and safety and comorbidity outcome classes. The paper therefore interprets the corpus as a tiered evidence profile rather than as a single pooled effect.", "The conclusion is that liraglutide metabolism effects should be treated as a bounded geroscience hypothesis: the retained clinical and adjacent evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim.", "The corpus contains 6 direct clinical sources, 6 adjacent clinical sources, and no sources classified primarily as mechanistic or model-system evidence. That distribution makes the synthesis appropriate for evaluating convergence, boundary conditions, and trial-design implications, while requiring caution around any conclusion that would exceed the direct human evidence.", "The thesis is: Across 12 curated reference papers, the evidence base for Liraglutide shows a context-dependent profile. Positive signals appear in: immune inflammation. Negative signals appear in: contextual other. Null findings dominate: cardiometabolic, contextual other. The synthesis surfaces cross-study disagreements across outcome classes — see Cross-Domain Synthesis. The Liraglutide anti-aging case as currently constituted is incomplete: mechanistic plausibility coexists with mixed or sparse human-RCT evidence, and the boundary conditions remain to be established. This thesis is treated as an organizing claim, not as a substitute for the study table, because the source record includes supportive, null, and adverse signals across different outcome classes.", "Null findings have a specific role in this evidence model. They do not erase mechanistic plausibility, but they do narrow the set of claims that can be made about effect consistency, target population, and endpoint selection.", "The evidence base also distinguishes breadth from certainty. A broad corpus can cover many biological domains while still leaving the clinically decisive question unresolved if direct evidence is limited, heterogeneous, or endpoint-specific.", "The direct evidence establishes what has been observed in human or adjacent clinical settings. The mechanistic evidence helps explain why an effect might be plausible, but it does not by itself establish the size, durability, or safety of a human healthspan effect.", "The study-level structure also prevents selective emphasis. Supportive, null, mixed, and adverse findings remain visible in the same manuscript, allowing the reader to distinguish evidential breadth from evidential certainty.", "Contextual Adjacent Evidence: n=6; claims=440; mixed signal in 2/6 sources | directness: 4 direct; 2 indirect; main limitation: directionally heterogeneous.", "A sex-stratified secondary finding from the same RCT is the most interpretively distinctive metabolic signal in the corpus: weight loss induced changes in vitamin D status in women with obesity but not in men (Holt 2024). The trial therefore delivers a mixed cardiometabolic profile rather than a uniform direction of effect, and the reader is referred to the evidence synthesis for the full per-comparison inventory."], "limitations": ["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."], "publication_id": "b5c45f8d-c264-403e-befa-f38d10ad33c1", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 12, "included": 12, "included_or_retained": 12, "screened": 12, "wording": "12 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "b5c45f8d-c264-403e-befa-f38d10ad33c1",
  "researka_submission_id": "2246e305-a6c2-4ae0-aa82-ed59686819c7",
  "sidecar_name": "contradiction_map.json",
  "sidecar_url": "https://api.researka.org/publications/b5c45f8d-c264-403e-befa-f38d10ad33c1/sidecars/contradiction_map.json"
}